WedSep 23rd, 2020
TueSep 22nd, 2020
TueSep 22nd, 2020
Lantern Pharma and Fox Chase Cancer Center Collaborate
Contract Pharma
ThuAug 13th, 2020
Taking on an IPO: How Lantern Pharma got it done amid COVID-19 — and the opportunities ahead
By Brian Womack, Dallas Business Journal
FriAug 7th, 2020
Lantern Pharma CEO Panna Sharma Talks Cancer Treatments, Earnings
TD Ameritrade Network
MonJul 20th, 2020
Lantern Pharma Establishes Manufacturing Network
Contract Pharma
Lantern Pharma is proud to be featured by a multitude of media outlets. Our goal is to crush cancer, and by spreading word of our innovative technology we hope to open the door to more collaborations and partnerships than ever, to empower us to develop the right treatments for the right patients.
Let’s start a conversation about the future of cancer drug development.
We are a biotech pharma at the intersection of Artificial Intelligence, genomics, and oncology drug development.